Agari Data, Inc. specializes in email security solutions, leveraging artificial intelligence to provide a secure email cloud platform. The company offers a comprehensive suite of products designed to detect, defend against, and deter advanced email threats, including phishing, spear phishing, account takeover, and business email compromise. Agari's services are tailored to various sectors, including financial institutions, government, and healthcare, focusing on reducing business risks and restoring trust in email communications. The platform utilizes applied data science and multiple signals to protect organizations from inbound attacks while also preventing the spoofing of outbound emails, thereby enhancing deliverability and safeguarding brand integrity. Founded in 2009 and based in Foster City, California, Agari was previously known as Authentication Metrics, Inc.
AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.
Agari Data, Inc. specializes in email security solutions, leveraging artificial intelligence to provide a secure email cloud platform. The company offers a comprehensive suite of products designed to detect, defend against, and deter advanced email threats, including phishing, spear phishing, account takeover, and business email compromise. Agari's services are tailored to various sectors, including financial institutions, government, and healthcare, focusing on reducing business risks and restoring trust in email communications. The platform utilizes applied data science and multiple signals to protect organizations from inbound attacks while also preventing the spoofing of outbound emails, thereby enhancing deliverability and safeguarding brand integrity. Founded in 2009 and based in Foster City, California, Agari was previously known as Authentication Metrics, Inc.
AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.
Agari Data, Inc. specializes in email security solutions, leveraging artificial intelligence to provide a secure email cloud platform. The company offers a comprehensive suite of products designed to detect, defend against, and deter advanced email threats, including phishing, spear phishing, account takeover, and business email compromise. Agari's services are tailored to various sectors, including financial institutions, government, and healthcare, focusing on reducing business risks and restoring trust in email communications. The platform utilizes applied data science and multiple signals to protect organizations from inbound attacks while also preventing the spoofing of outbound emails, thereby enhancing deliverability and safeguarding brand integrity. Founded in 2009 and based in Foster City, California, Agari was previously known as Authentication Metrics, Inc.
GigaOm is a media company based in San Francisco that specializes in providing news, analysis, and insights on startups and emerging technologies. Founded in 2006 by Om Malik, GigaOm attracts over 6.5 million unique readers monthly, offering content that helps them navigate major technology disruptions and explore new business opportunities. The company employs a network of over 200 independent analysts who generate timely, in-depth research, bridging the gap between breaking news and long-term trends. GigaOm also organizes events that combine focused editorial content with opportunities for attendees to engage with technology disruptors, equipping them with the knowledge necessary to capitalize on emerging trends.
Grand Junction, Inc., based in San Francisco, California, is a transportation technology company that specializes in providing same-day delivery solutions through its Software-as-a-Service platform. Founded in 2000 and acquired by Target Corporation in 2017, Grand Junction serves a diverse clientele, including small to medium-sized businesses, large enterprises, and individual consumers across the United States and Canada. The company manages nearly 100 million deliveries to date, leveraging a network of 700 local carriers. Its comprehensive platform allows users to customize delivery services, offering options such as on-demand, scheduled, and two-person delivery. Additionally, Grand Junction's technology enhances operational efficiency by providing tools for route optimization, delivery tracking, and performance monitoring, ultimately reducing costs and improving customer satisfaction.
Hightail is a cloud service that lets users send, receive, digitally sign, and synchronize files. Hightail addresses the problems of creative collaboration and visual project management between teams of creative professionals and their clients and other stakeholders. An innovator in the cloud since before the term was even coined, Hightail (FKA YouSendIt) began as a simple way to send files that were too large for email and have since grown to evolve the cloud into a virtual workspace that enables seamless collaboration on visual projects from concept to completion.
Scifiniti is an early-stage company focused on developing innovative technology for photovoltaic cells. The company aims to provide a low-cost, drop-in replacement for traditional crystalline silicon wafers by directly creating high-quality wafers with a suitable crystal structure for solar applications. This novel approach eliminates the need for the conventional processes of casting polysilicon ingots and sawing them into wafers, potentially enhancing performance and reducing production costs in the solar energy market. By streamlining the manufacturing process, Scifiniti's technology could significantly impact the solar industry, enabling businesses to produce and sell more efficient solar modules.
OptiMedica Corporation is a Silicon Valley-based ophthalmic device company founded in 2004, dedicated to enhancing patient outcomes through innovative technologies. The company focuses on developing a reproducible, noninvasive technique to improve cataract surgery by utilizing femtosecond laser technology, which aims to replace the inconsistent manual steps traditionally associated with the procedure. This advancement is designed to provide cataract surgeons and their patients with improved precision, control, and performance. OptiMedica has successfully completed clinical trials of its Catalys Precision Laser System, yielding promising results. Although the system is not yet available for sale in the United States, the company anticipates launching it in U.S. and international markets.
RainDance Technologies, Inc. specializes in developing genomic tools for non-invasive liquid biopsy applications, focusing on the research, early detection, and treatment of cancer and other diseases. The company offers a range of products, including the RainDrop digital polymerase chain reaction platform, which utilizes picoliter-sized droplets for the multiplex detection of various genetic materials such as DNA and RNA. Additionally, it provides the RainDrop Plus system for next-generation sequencing (NGS) amplicon enrichment and the ThunderStorm automated NGS content enrichment solution, which enhances the processing of samples and data quality. RainDance also offers targeted NGS panels like ThunderBolts, aimed at profiling cancer mutations and understanding myeloid disorders. The company serves major research institutions and laboratories globally through a network of sales representatives and distributors. Founded in 2004 and based in Billerica, Massachusetts, RainDance Technologies operates as a subsidiary of Bio-Rad Laboratories, Inc.
Labcyte Inc. is a specialized laboratory instrumentation company based in San Jose, California, established in 2000. It focuses on acoustic droplet ejection (ADE) technology, which enables the precise dispensing of nanoliter-scale droplets for various life sciences applications, including drug discovery, genomics research, cancer research, and diagnostic testing. The company's flagship product, Echo, utilizes a focused beam of acoustic energy to transfer small volumes of liquids with high accuracy and minimal waste, thereby reducing consumable costs. Labcyte also offers a range of automation systems, laboratory workstations, and control software to enhance laboratory efficiency. As a subsidiary of Beckman Coulter, Inc., Labcyte has expanded its presence internationally, with offices in countries such as Canada, the United Kingdom, Australia, and several others across Asia. The company was previously known as Picoliter Inc. until it rebranded in 2003.
Genomatica, Inc. specializes in developing innovative manufacturing processes that convert renewable feedstocks into intermediate and basic chemicals. Utilizing its proprietary biotechnology platform, the company engineers microorganisms to facilitate fermentation-based production, focusing on a pipeline of 20 key chemicals, including butanediol and butadiene. Genomatica has established itself as a leader in bioengineering, aiming to foster a transition to sustainable materials. Its technology has gained recognition for commercializing processes for butanediol, used in biodegradable plastics and apparel, and butylene glycol, which is important in cosmetics and personal care products. The company is also advancing research in bio-nylon. Genomatica's achievements have been acknowledged through several awards, including the Kirkpatrick Award for outstanding chemical engineering technology and the ICIS Innovation Award for its Brontide butylene glycol. Founded in 1998 and headquartered in San Diego, California, Genomatica focuses on enhancing the economics, sustainability, and performance of chemical production.
Siluria Technologies is a materials innovation company solving global challenges for partners in the natural gas, chemicals and fuel industries. Integrating nanotechnology, biotechnology and chemical engineering, Siluria has developed a solution to the grand challenge of efficient manufacturing: the ability to produce chemicals and fuels from a cheaper, more abundant resource than oil. The company's economically superior, energy-efficient platform converts natural gas into the same materials manufactured today using current industry infrastructure. Siluria's world-class R&D and engineering teams are rapidly commercializing the company's technology to pilot-scale production in close dialogue with the world's largest chemical and fuel companies.Siluria's backers include Alloy Ventures, ARCH Venture Partners, Kleiner Perkins Caufield & Byers, Altitude Life Science Ventures, Lux Capital, and Presidio Ventures.
Local delivery companies do everything in a supply chain’s “last mile,” from installing appliances to delivering critical parts within an hour of ordering. Local delivery is a $46 billion industry and typically accounts for 28% of a company's transportation spend, yet most companies overlook this critical step in the supply chain despite the fact that customer loyalty and sales are closely tied to the delivery experience.
Ensenda is the leading third party logistics provider (3PL) for the local delivery industry. Ensenda’ network of local carriers provides a wide range of local delivery programs in every market in the US and Canada
Agari Data, Inc. specializes in email security solutions, leveraging artificial intelligence to provide a secure email cloud platform. The company offers a comprehensive suite of products designed to detect, defend against, and deter advanced email threats, including phishing, spear phishing, account takeover, and business email compromise. Agari's services are tailored to various sectors, including financial institutions, government, and healthcare, focusing on reducing business risks and restoring trust in email communications. The platform utilizes applied data science and multiple signals to protect organizations from inbound attacks while also preventing the spoofing of outbound emails, thereby enhancing deliverability and safeguarding brand integrity. Founded in 2009 and based in Foster City, California, Agari was previously known as Authentication Metrics, Inc.
Siluria Technologies is a materials innovation company solving global challenges for partners in the natural gas, chemicals and fuel industries. Integrating nanotechnology, biotechnology and chemical engineering, Siluria has developed a solution to the grand challenge of efficient manufacturing: the ability to produce chemicals and fuels from a cheaper, more abundant resource than oil. The company's economically superior, energy-efficient platform converts natural gas into the same materials manufactured today using current industry infrastructure. Siluria's world-class R&D and engineering teams are rapidly commercializing the company's technology to pilot-scale production in close dialogue with the world's largest chemical and fuel companies.Siluria's backers include Alloy Ventures, ARCH Venture Partners, Kleiner Perkins Caufield & Byers, Altitude Life Science Ventures, Lux Capital, and Presidio Ventures.
Verinata Health focuses on maternal and fetal health by developing non-invasive tests for the early identification of fetal chromosomal abnormalities. Utilizing proprietary technologies, the company analyzes cell-free DNA in maternal blood to offer a safe and accurate assessment of fetal aneuploidy. This approach aims to alleviate the anxiety associated with traditional prenatal screening methods that often involve multiple steps, high false-positive rates, and invasive procedures. Verinata seeks to provide women with a straightforward solution, consisting of a single blood draw that delivers definitive results. The company is also conducting a large-scale, prospective, blinded pivotal study to validate the sensitivity and specificity of its prenatal test, with results anticipated to enhance the understanding and effectiveness of prenatal care.
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.
Crux Biomedical, Inc., established in August 2004 by physicians Tom Fogarty and Frank Arko, focuses on developing innovative medical devices to address the limitations of existing vena cava filters. The company's primary product, the Crux VCF System, serves as a preventive device for pulmonary embolisms, effectively stopping blood clots from reaching the lungs. This system is particularly beneficial for patients at risk of pulmonary embolism who are unable to tolerate blood thinners, providing a vital method for preventing potentially life-threatening clots.
Infineta Systems is a privately-held network infrastructure company that develops and markets a line of high-performance network optimization products. Infineta’s system architecture will power a generation of products to address the urgent need for high-speed enterprise data center interconnects. Infineta is pioneering a new category of products that will help Global 2000 enterprises address the explosion in inter-data center traffic resulting from mission-critical storage replication, backup and emerging “private cloud†applications. At the center of this architecture is Infineta’s patent-pending Velocity Dedupe Engine™. The Velocity Dedupe Engine is providing an innovative, hardware-based solution to obtain the high throughput and zero-latency requirements necessary for today’s enterprise data centers. Infineta offers customers dramatically lower costs and more control of their critical data center-to-data center traffic. Customers leverage the Infineta solution to build high-performance inter-data center fabric, transforming a rigid and inflexible model into an agile ‘global area network’ of pooled resources for a more powerful and cost-effective computing experience.
Mavenir is a cloud-native network software provider that focuses on transforming network infrastructure for Communications Service Providers (CSPs). The company offers a comprehensive product portfolio that spans all layers of network infrastructure, including 5G applications, packet core, and radio access networks (RAN). Mavenir's innovative solutions have established it as a leader in evolved networking, with notable advancements in technologies such as VoLTE, VoWiFi, Advanced Messaging, and virtualized RAN. The company serves over 250 CSP customers in more than 130 countries, impacting more than half of the world's subscribers. By leveraging disruptive technologies and business models, Mavenir aims to enhance service agility, flexibility, and efficiency while helping CSPs reduce costs and protect revenue.
GigaOm is a media company based in San Francisco that specializes in providing news, analysis, and insights on startups and emerging technologies. Founded in 2006 by Om Malik, GigaOm attracts over 6.5 million unique readers monthly, offering content that helps them navigate major technology disruptions and explore new business opportunities. The company employs a network of over 200 independent analysts who generate timely, in-depth research, bridging the gap between breaking news and long-term trends. GigaOm also organizes events that combine focused editorial content with opportunities for attendees to engage with technology disruptors, equipping them with the knowledge necessary to capitalize on emerging trends.
AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.
Cameron Health, Inc. is a development stage medical device company focused on creating advanced implantable electronic devices. The company specializes in the development of the subcutaneous implantable defibrillator (S-ICD) system, designed to protect patients from sudden cardiac arrest. By leveraging state-of-the-art technologies and a team of experienced professionals, Cameron Health aims to address complex medical challenges and provide innovative treatment options that have been previously unattainable with existing therapies.
RainDance Technologies, Inc. specializes in developing genomic tools for non-invasive liquid biopsy applications, focusing on the research, early detection, and treatment of cancer and other diseases. The company offers a range of products, including the RainDrop digital polymerase chain reaction platform, which utilizes picoliter-sized droplets for the multiplex detection of various genetic materials such as DNA and RNA. Additionally, it provides the RainDrop Plus system for next-generation sequencing (NGS) amplicon enrichment and the ThunderStorm automated NGS content enrichment solution, which enhances the processing of samples and data quality. RainDance also offers targeted NGS panels like ThunderBolts, aimed at profiling cancer mutations and understanding myeloid disorders. The company serves major research institutions and laboratories globally through a network of sales representatives and distributors. Founded in 2004 and based in Billerica, Massachusetts, RainDance Technologies operates as a subsidiary of Bio-Rad Laboratories, Inc.
GigaOm is a media company based in San Francisco that specializes in providing news, analysis, and insights on startups and emerging technologies. Founded in 2006 by Om Malik, GigaOm attracts over 6.5 million unique readers monthly, offering content that helps them navigate major technology disruptions and explore new business opportunities. The company employs a network of over 200 independent analysts who generate timely, in-depth research, bridging the gap between breaking news and long-term trends. GigaOm also organizes events that combine focused editorial content with opportunities for attendees to engage with technology disruptors, equipping them with the knowledge necessary to capitalize on emerging trends.
Siluria Technologies is a materials innovation company solving global challenges for partners in the natural gas, chemicals and fuel industries. Integrating nanotechnology, biotechnology and chemical engineering, Siluria has developed a solution to the grand challenge of efficient manufacturing: the ability to produce chemicals and fuels from a cheaper, more abundant resource than oil. The company's economically superior, energy-efficient platform converts natural gas into the same materials manufactured today using current industry infrastructure. Siluria's world-class R&D and engineering teams are rapidly commercializing the company's technology to pilot-scale production in close dialogue with the world's largest chemical and fuel companies.Siluria's backers include Alloy Ventures, ARCH Venture Partners, Kleiner Perkins Caufield & Byers, Altitude Life Science Ventures, Lux Capital, and Presidio Ventures.
Ciranova, Inc. operates as an electronic design automation company. It focuses on building interoperable tools for custom chip designers to create new and/or migrate legacy analog IP. It offers products, such as PyCell Studio, which helps designers reduce the time and cost of PCell and layout generator creation for deep submicron processes; and PCell Xtreme, which enables the migration of PCells created in proprietary languages into multi-vendor OpenAccess flows. It provides custom layout generator development, Python code development consulting, custom layout consulting, and analog and mixed signal design services. The company was founded in 2002 and is headquartered in Santa Clara, California.
Xactly is a prominent global provider of cloud-based Sales Performance Management solutions designed to enhance the effectiveness of sales organizations. The company offers tools for sales quota and territory planning, as well as incentive compensation management and predictive analytics. Its Xactly Incent Suite is specifically designed to drive sales behavior in alignment with organizational goals, promoting employee trust and loyalty through accurate commission payments and transparent access to performance data. By improving operational efficiency and productivity, Xactly aims to empower organizations to optimize their sales strategies and achieve better results.
Hightail is a cloud service that lets users send, receive, digitally sign, and synchronize files. Hightail addresses the problems of creative collaboration and visual project management between teams of creative professionals and their clients and other stakeholders. An innovator in the cloud since before the term was even coined, Hightail (FKA YouSendIt) began as a simple way to send files that were too large for email and have since grown to evolve the cloud into a virtual workspace that enables seamless collaboration on visual projects from concept to completion.
BÂRRX Medical, Inc. develops endoscopic treatment solutions for Barrett's esophagus and other chronic gastroenterological diseases. Barrett's is a precancerous condition of the lining of the esophagus (swallowing tube) caused by gastroesophageal reflux disease, or GERD. The company's HALOFLEX, HALO360 and HALO90 ablation systems are designed to provide a uniform and controlled ablation effect, in order to remove diseased tissue and allow re-growth of normal cells. A multi-center randomized, sham-controlled study, published in the New England Journal of Medicine in 2009, studied HALO radiofrequency ablation applied in the highest risk Barrett's population (those having dysplasia). The ablation group had a high rate of complete eradication of dysplasia and intestinal metaplasia and a significantly decreased rate of disease progression and cancer development, as compared to the control group. In another study (AIM-II) published in Gastrointestinal Endoscopy, 98.4% of treated patients were Barrett's-free after two and a half years of follow-up. The HALO systems are cleared by the FDA for use in the United States and each have CE Mark for use in Europe. More than 58,000 procedures have been performed in over 400 hospitals around the world. Based in Sunnyvale, Calif., BÂRRX Medical, Inc. was founded in 2000 and is privately-held.
Pacific Biosciences designs, develops, and manufactures advanced sequencing systems that address complex genetic challenges. Utilizing single molecule real-time (SMRT) sequencing technology, it enables the real-time detection of biological processes at the single-molecule level. The company offers products such as the PacBio RS II and Sequel Systems, which are capable of conducting, monitoring, and analyzing biochemical reactions in real time. In addition to sequencing systems, Pacific Biosciences provides consumables like SMRT cells and various reagent kits essential for template preparation, binding, and sequencing. Its diverse customer base includes research institutions, commercial laboratories, genome centers, and various sectors such as pharmaceuticals and agriculture. The company markets its products through a direct sales force in North America and Europe, along with distribution partners in Asia, the Middle East, and Latin America. Founded in 2000, Pacific Biosciences is headquartered in Menlo Park, California.
Xactly is a prominent global provider of cloud-based Sales Performance Management solutions designed to enhance the effectiveness of sales organizations. The company offers tools for sales quota and territory planning, as well as incentive compensation management and predictive analytics. Its Xactly Incent Suite is specifically designed to drive sales behavior in alignment with organizational goals, promoting employee trust and loyalty through accurate commission payments and transparent access to performance data. By improving operational efficiency and productivity, Xactly aims to empower organizations to optimize their sales strategies and achieve better results.
Mavenir is a cloud-native network software provider that focuses on transforming network infrastructure for Communications Service Providers (CSPs). The company offers a comprehensive product portfolio that spans all layers of network infrastructure, including 5G applications, packet core, and radio access networks (RAN). Mavenir's innovative solutions have established it as a leader in evolved networking, with notable advancements in technologies such as VoLTE, VoWiFi, Advanced Messaging, and virtualized RAN. The company serves over 250 CSP customers in more than 130 countries, impacting more than half of the world's subscribers. By leveraging disruptive technologies and business models, Mavenir aims to enhance service agility, flexibility, and efficiency while helping CSPs reduce costs and protect revenue.
Apptera is a mobile communications and advertising company that specializes in delivering multimedia content and interactive experiences to mobile devices. Its flagship product, Raved, enhances consumer engagement while the Apptera MobileAd Network connects advertisers with a diverse array of publishers, enabling effective outreach to millions of mobile users. The company collaborates with notable partners such as AOL Moviefone and Movietickets.com to maximize advertising impact. Founded in 2001 and based in Silicon Valley, Apptera has received several industry accolades, including recognition as one of the OnMobile 100 Top Private Companies in 2011. The company also holds multiple patents related to its communications technology, underscoring its innovative approach in the mobile advertising space. Apptera maintains additional offices in New York and Los Angeles, reflecting its expansive operational footprint.
Scifiniti is an early-stage company focused on developing innovative technology for photovoltaic cells. The company aims to provide a low-cost, drop-in replacement for traditional crystalline silicon wafers by directly creating high-quality wafers with a suitable crystal structure for solar applications. This novel approach eliminates the need for the conventional processes of casting polysilicon ingots and sawing them into wafers, potentially enhancing performance and reducing production costs in the solar energy market. By streamlining the manufacturing process, Scifiniti's technology could significantly impact the solar industry, enabling businesses to produce and sell more efficient solar modules.
Infineta Systems is a privately-held network infrastructure company that develops and markets a line of high-performance network optimization products. Infineta’s system architecture will power a generation of products to address the urgent need for high-speed enterprise data center interconnects. Infineta is pioneering a new category of products that will help Global 2000 enterprises address the explosion in inter-data center traffic resulting from mission-critical storage replication, backup and emerging “private cloud†applications. At the center of this architecture is Infineta’s patent-pending Velocity Dedupe Engine™. The Velocity Dedupe Engine is providing an innovative, hardware-based solution to obtain the high throughput and zero-latency requirements necessary for today’s enterprise data centers. Infineta offers customers dramatically lower costs and more control of their critical data center-to-data center traffic. Customers leverage the Infineta solution to build high-performance inter-data center fabric, transforming a rigid and inflexible model into an agile ‘global area network’ of pooled resources for a more powerful and cost-effective computing experience.
Genomatica, Inc. specializes in developing innovative manufacturing processes that convert renewable feedstocks into intermediate and basic chemicals. Utilizing its proprietary biotechnology platform, the company engineers microorganisms to facilitate fermentation-based production, focusing on a pipeline of 20 key chemicals, including butanediol and butadiene. Genomatica has established itself as a leader in bioengineering, aiming to foster a transition to sustainable materials. Its technology has gained recognition for commercializing processes for butanediol, used in biodegradable plastics and apparel, and butylene glycol, which is important in cosmetics and personal care products. The company is also advancing research in bio-nylon. Genomatica's achievements have been acknowledged through several awards, including the Kirkpatrick Award for outstanding chemical engineering technology and the ICIS Innovation Award for its Brontide butylene glycol. Founded in 1998 and headquartered in San Diego, California, Genomatica focuses on enhancing the economics, sustainability, and performance of chemical production.
Integrated Photovoltaics is a leading developer of next-generation photovoltaic solutions. Integrated Photovoltaics is a privately held company headquartered in Sunnyvale, California.
Fluidigm Corporation develops and markets innovative technologies and tools for life sciences research globally. The company specializes in integrated fluidic circuits that control fluids at the nanoscale, enabling a range of applications in biological research. Its product offerings include analytical systems such as the Helios CyTOF system, the Hyperion imaging system, and the Biomark HD system, along with various assays and reagents designed for immuno-oncology and genetic analysis. Fluidigm also provides preparatory instruments and single-cell microfluidics, such as the C1 and Polaris systems. The company serves a diverse clientele, including academic institutions, clinical research laboratories, biopharmaceutical, biotechnology, and agricultural biotechnology companies, focusing on non-diagnostic and non-clinical applications. Established in 1999 as Mycometrix Corporation, it adopted the name Fluidigm Corporation in 2001 and is headquartered in South San Francisco, California.
Cambrios Technologies Corp. develops electronic materials for the display industry. The company provides wet-processable transparent conductive films. Its nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components. The company was founded in 2002 as Semzyme, Inc. and changed its name to Cambrios Technologies Corp. in August 2004. Cambrios Technologies Corp. is based in Sunnyvale, California.
Ravenflow enables enterprises to deliver applications faster. RAVEN software for requirements elicitation and definition quickly builds stakeholder consensus on requirements, reduces the time required for stakeholders to approve specifications, reduces developer rework due to requirements errors, and seamlessly integrates requirements and testing. RAVEN integrates requirements elicitation and definition with the application lifecycle management platforms from IBM Rational, Telelogic, HP Mercury, and also Microsoft Visual Studio.
Teradici Corporation specializes in PC-over-IP (PCoIP) technology, which facilitates the transfer of images from centralized servers or workstations to various PCoIP-ready endpoints. This technology enhances the provisioning and management of computing services, supporting diverse work styles including remote, mobile, and collaborative environments. Teradici's offerings encompass a range of solutions such as zero clients, optimized thin clients, hardware accelerators, remote workstation cards, workstation access software, and a management console for enterprise deployment. These products cater to industries like education, financial services, healthcare, media and entertainment, and architecture, among others. The company also provides cloud solutions, desktop virtualization infrastructure, and support services. Teradici's clientele includes Fortune 500 companies, government agencies, and cloud service providers, and it collaborates with OEM partners globally. Founded in 2004 and headquartered in Burnaby, Canada, Teradici is committed to innovation and has secured over 40 patents in its field.
SynergEyes, Inc. is a technology-driven company specializing in the manufacture and sale of contact lenses for eye care professionals. Founded in 2001 and based in Carlsbad, California, SynergEyes focuses on hybrid contact lenses that combine the clarity of rigid gas permeable lenses with the comfort of soft lenses. Their product offerings cater to various eye conditions, including astigmatism, presbyopia, myopia, hyperopia, and keratoconus. By utilizing advanced high-Dk materials and vision-optimized designs, SynergEyes aims to enhance vision and quality of life for its patients. The company's products are distributed in the United States and internationally, addressing a recognized need for innovative lens solutions in the eye care industry.
Crux Biomedical, Inc., established in August 2004 by physicians Tom Fogarty and Frank Arko, focuses on developing innovative medical devices to address the limitations of existing vena cava filters. The company's primary product, the Crux VCF System, serves as a preventive device for pulmonary embolisms, effectively stopping blood clots from reaching the lungs. This system is particularly beneficial for patients at risk of pulmonary embolism who are unable to tolerate blood thinners, providing a vital method for preventing potentially life-threatening clots.
Humanigen, Inc. is a clinical-stage biopharmaceutical company based in Burlingame, California, that specializes in the development of proprietary monoclonal antibodies for immunotherapy and oncology. The company's lead product candidate, Lenzilumab, targets granulocyte-macrophage colony-stimulating factor and is currently undergoing Phase Ib/II clinical trials for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia. Additionally, Humanigen is developing Ifabotuzumab, which targets the EphA3 receptor and has completed the Phase I dose escalation in multiple hematologic malignancies, as well as HGEN005, an anti-EMR1 monoclonal antibody in pre-clinical stages for eosinophilic diseases. The company collaborates with Kite Pharma to conduct a multi-center Phase Ib/II study of Lenzilumab in patients with relapsed or refractory diffuse large B-cell lymphoma and has partnered with the Department of Defense to further develop Lenzilumab for potential emergency use in COVID-19. Founded in 2000, Humanigen was formerly known as KaloBios Pharmaceuticals and rebranded in August 2017.
Mavenir is a cloud-native network software provider that focuses on transforming network infrastructure for Communications Service Providers (CSPs). The company offers a comprehensive product portfolio that spans all layers of network infrastructure, including 5G applications, packet core, and radio access networks (RAN). Mavenir's innovative solutions have established it as a leader in evolved networking, with notable advancements in technologies such as VoLTE, VoWiFi, Advanced Messaging, and virtualized RAN. The company serves over 250 CSP customers in more than 130 countries, impacting more than half of the world's subscribers. By leveraging disruptive technologies and business models, Mavenir aims to enhance service agility, flexibility, and efficiency while helping CSPs reduce costs and protect revenue.
Apptera is a mobile communications and advertising company that specializes in delivering multimedia content and interactive experiences to mobile devices. Its flagship product, Raved, enhances consumer engagement while the Apptera MobileAd Network connects advertisers with a diverse array of publishers, enabling effective outreach to millions of mobile users. The company collaborates with notable partners such as AOL Moviefone and Movietickets.com to maximize advertising impact. Founded in 2001 and based in Silicon Valley, Apptera has received several industry accolades, including recognition as one of the OnMobile 100 Top Private Companies in 2011. The company also holds multiple patents related to its communications technology, underscoring its innovative approach in the mobile advertising space. Apptera maintains additional offices in New York and Los Angeles, reflecting its expansive operational footprint.
Apptera is a mobile communications and advertising company that specializes in delivering multimedia content and interactive experiences to mobile devices. Its flagship product, Raved, enhances consumer engagement while the Apptera MobileAd Network connects advertisers with a diverse array of publishers, enabling effective outreach to millions of mobile users. The company collaborates with notable partners such as AOL Moviefone and Movietickets.com to maximize advertising impact. Founded in 2001 and based in Silicon Valley, Apptera has received several industry accolades, including recognition as one of the OnMobile 100 Top Private Companies in 2011. The company also holds multiple patents related to its communications technology, underscoring its innovative approach in the mobile advertising space. Apptera maintains additional offices in New York and Los Angeles, reflecting its expansive operational footprint.
Verinata Health focuses on maternal and fetal health by developing non-invasive tests for the early identification of fetal chromosomal abnormalities. Utilizing proprietary technologies, the company analyzes cell-free DNA in maternal blood to offer a safe and accurate assessment of fetal aneuploidy. This approach aims to alleviate the anxiety associated with traditional prenatal screening methods that often involve multiple steps, high false-positive rates, and invasive procedures. Verinata seeks to provide women with a straightforward solution, consisting of a single blood draw that delivers definitive results. The company is also conducting a large-scale, prospective, blinded pivotal study to validate the sensitivity and specificity of its prenatal test, with results anticipated to enhance the understanding and effectiveness of prenatal care.
GigaOm is a media company based in San Francisco that specializes in providing news, analysis, and insights on startups and emerging technologies. Founded in 2006 by Om Malik, GigaOm attracts over 6.5 million unique readers monthly, offering content that helps them navigate major technology disruptions and explore new business opportunities. The company employs a network of over 200 independent analysts who generate timely, in-depth research, bridging the gap between breaking news and long-term trends. GigaOm also organizes events that combine focused editorial content with opportunities for attendees to engage with technology disruptors, equipping them with the knowledge necessary to capitalize on emerging trends.
ForteBio is a life science company focused on developing analytical systems for protein quantification and the characterization of protein-protein interactions. The company offers the Octet family of instruments, which facilitate real-time analysis of biomolecular interactions using micro-volume samples. These instruments provide essential data on affinity, kinetics, and concentration for proteins, peptides, DNA, RNA, and small molecules. Key products in the Octet line include the Octet RED, which is designed for quantitation and kinetics analysis while also enhancing the range and resolution for small molecule screening, as well as the Octet Q and QK models that perform similar analytical functions. By enabling rapid, real-time results, ForteBio's systems support scientists in their research endeavors.
Humanigen, Inc. is a clinical-stage biopharmaceutical company based in Burlingame, California, that specializes in the development of proprietary monoclonal antibodies for immunotherapy and oncology. The company's lead product candidate, Lenzilumab, targets granulocyte-macrophage colony-stimulating factor and is currently undergoing Phase Ib/II clinical trials for chronic myelomonocytic leukemia and juvenile myelomonocytic leukemia. Additionally, Humanigen is developing Ifabotuzumab, which targets the EphA3 receptor and has completed the Phase I dose escalation in multiple hematologic malignancies, as well as HGEN005, an anti-EMR1 monoclonal antibody in pre-clinical stages for eosinophilic diseases. The company collaborates with Kite Pharma to conduct a multi-center Phase Ib/II study of Lenzilumab in patients with relapsed or refractory diffuse large B-cell lymphoma and has partnered with the Department of Defense to further develop Lenzilumab for potential emergency use in COVID-19. Founded in 2000, Humanigen was formerly known as KaloBios Pharmaceuticals and rebranded in August 2017.
3Leaf Systems specializes in server virtualization solutions that enhance corporate data center initiatives, focusing on power management and optimized scale-out architectures. Their Virtual Compute Environment (VCE) architecture provides system-level virtualization, allowing organizations to achieve mainframe-class capabilities on commodity servers. By utilizing 3Leaf's technology, businesses can significantly lower their infrastructure and operational costs while enabling rapid deployment and provisioning of data center resources. This ensures that organizations can meet the demands of modern applications effectively.
Hightail is a cloud service that lets users send, receive, digitally sign, and synchronize files. Hightail addresses the problems of creative collaboration and visual project management between teams of creative professionals and their clients and other stakeholders. An innovator in the cloud since before the term was even coined, Hightail (FKA YouSendIt) began as a simple way to send files that were too large for email and have since grown to evolve the cloud into a virtual workspace that enables seamless collaboration on visual projects from concept to completion.
Pacific Biosciences designs, develops, and manufactures advanced sequencing systems that address complex genetic challenges. Utilizing single molecule real-time (SMRT) sequencing technology, it enables the real-time detection of biological processes at the single-molecule level. The company offers products such as the PacBio RS II and Sequel Systems, which are capable of conducting, monitoring, and analyzing biochemical reactions in real time. In addition to sequencing systems, Pacific Biosciences provides consumables like SMRT cells and various reagent kits essential for template preparation, binding, and sequencing. Its diverse customer base includes research institutions, commercial laboratories, genome centers, and various sectors such as pharmaceuticals and agriculture. The company markets its products through a direct sales force in North America and Europe, along with distribution partners in Asia, the Middle East, and Latin America. Founded in 2000, Pacific Biosciences is headquartered in Menlo Park, California.
Verinata Health focuses on maternal and fetal health by developing non-invasive tests for the early identification of fetal chromosomal abnormalities. Utilizing proprietary technologies, the company analyzes cell-free DNA in maternal blood to offer a safe and accurate assessment of fetal aneuploidy. This approach aims to alleviate the anxiety associated with traditional prenatal screening methods that often involve multiple steps, high false-positive rates, and invasive procedures. Verinata seeks to provide women with a straightforward solution, consisting of a single blood draw that delivers definitive results. The company is also conducting a large-scale, prospective, blinded pivotal study to validate the sensitivity and specificity of its prenatal test, with results anticipated to enhance the understanding and effectiveness of prenatal care.
Moxsie is an online retailer where shoppers can discover independent fashion - including clothing, footwear and accessories from new, up and coming designers.
Zannel makes the mobile industry's first Instant Media Network(TM), which allows people to instantly and visually communicate what's happening now across mobile and the web, including all major social networks. Zannel won a Webby for Best Mobile Social Network in 2008, serves million of unique visitors per month, has over 50 partnerships with leading operators, media companies, and brands. Founded by the team that built the first large-scale mobile media storefronts in the US, Zannel combines the best of mobile messaging, media sharing, and social networking into an intuitive, compelling user experience. Located in San Francisco, Zannel is backed by USVP, Alloy, and Palomar Ventures.
Molecular Imprints Inc., founded in 2001 and based in Austin, Texas, specializes in manufacturing imprint and lithography systems designed for creating nanometer-scale surface relief structures. The company is recognized for its Jet and Flash imprint lithography technology, which offers advanced nanopatterning capabilities for various high-tech industries, including displays, life sciences, and light-emitting diodes. With a robust intellectual property portfolio, Molecular Imprints has applied for over 700 patents, resulting in more than 100 issued patents that encompass imprint tools, materials, and process technology. The core of its technology, the Jet and Flash Imprint Lithography, employs the IntelliJet Drop Pattern Generator to achieve precise placement of photoresist on substrates in extremely small volumes, facilitating the uniform imprinting of features down to 10 nanometers and below. Through a combination of specialized competencies and strategic partnerships, Molecular Imprints delivers innovative solutions that meet the demanding needs of its customers.
At NovaSys Health they value your participation as a contracted provider. Roughly 11,000 providers in this region and over 4,300 providers in Arkansas have contracted with NovaSys Health making it one of the largest health plans in Arkansas. They take pride in the relationships that they have cultivated with providers.
$25 million in Series C preferred stock financing. The financing will be used to ramp up operations and prepare for sales and marketing in anticipation of the company commercializing its first product, the Novasys Micro-remodeling™ System. The system, which is designed to treat female stress urinary incontinence (SUI), has received the CE Mark for use in the European Union and is pending FDA marketing clearance for sale in the United States. Novasys Medical Inc is testing a new, non-incisional, transurethral treatment which requires no visualization of the treatment site (neither cystoscopy nor fluoroscopy), being guided by familiar balloon palpation (similar to a Foley catheter). In addition, the Novasys Micro-remodeling™ System incorporates numerous, automatic safety features making the treatment process very easy to learn and use. The treatment does not require general anesthesia and is performed in the outpatient or office setting. Not only is the treatment rapid (less than 10 minutes), but patients immediately return to virtually all activities. As there are no incisions, no wound care or dressing changes are required.
Xactly is a prominent global provider of cloud-based Sales Performance Management solutions designed to enhance the effectiveness of sales organizations. The company offers tools for sales quota and territory planning, as well as incentive compensation management and predictive analytics. Its Xactly Incent Suite is specifically designed to drive sales behavior in alignment with organizational goals, promoting employee trust and loyalty through accurate commission payments and transparent access to performance data. By improving operational efficiency and productivity, Xactly aims to empower organizations to optimize their sales strategies and achieve better results.
OptiMedica Corporation is a Silicon Valley-based ophthalmic device company founded in 2004, dedicated to enhancing patient outcomes through innovative technologies. The company focuses on developing a reproducible, noninvasive technique to improve cataract surgery by utilizing femtosecond laser technology, which aims to replace the inconsistent manual steps traditionally associated with the procedure. This advancement is designed to provide cataract surgeons and their patients with improved precision, control, and performance. OptiMedica has successfully completed clinical trials of its Catalys Precision Laser System, yielding promising results. Although the system is not yet available for sale in the United States, the company anticipates launching it in U.S. and international markets.
Labcyte Inc. is a specialized laboratory instrumentation company based in San Jose, California, established in 2000. It focuses on acoustic droplet ejection (ADE) technology, which enables the precise dispensing of nanoliter-scale droplets for various life sciences applications, including drug discovery, genomics research, cancer research, and diagnostic testing. The company's flagship product, Echo, utilizes a focused beam of acoustic energy to transfer small volumes of liquids with high accuracy and minimal waste, thereby reducing consumable costs. Labcyte also offers a range of automation systems, laboratory workstations, and control software to enhance laboratory efficiency. As a subsidiary of Beckman Coulter, Inc., Labcyte has expanded its presence internationally, with offices in countries such as Canada, the United Kingdom, Australia, and several others across Asia. The company was previously known as Picoliter Inc. until it rebranded in 2003.
Ciranova, Inc. operates as an electronic design automation company. It focuses on building interoperable tools for custom chip designers to create new and/or migrate legacy analog IP. It offers products, such as PyCell Studio, which helps designers reduce the time and cost of PCell and layout generator creation for deep submicron processes; and PCell Xtreme, which enables the migration of PCells created in proprietary languages into multi-vendor OpenAccess flows. It provides custom layout generator development, Python code development consulting, custom layout consulting, and analog and mixed signal design services. The company was founded in 2002 and is headquartered in Santa Clara, California.
Retrevo is an online shopping platform dedicated to consumer electronics, offering a comprehensive service for product search, discovery, recommendations, and purchasing. It aggregates and analyzes information from various sources, including expert reviews, user feedback, and technical manuals, to provide users with insightful and objective guidance on a wide range of electronic products such as cameras, laptops, audio equipment, and more. Utilizing machine learning and big data analytics, Retrevo continually updates its offerings to ensure consumers have access to the latest information and trends in the electronics market. Competing with other consumer electronics platforms, Retrevo positions itself as a leading resource for individuals looking to make informed purchasing decisions.
AEGEA Medical is pioneering the application of its Adaptive Vapor Ablation technology to deliver therapies that provide high quality patient outcomes to a wider range of patients. AEGEA’s FDA approved water vapor technology enables the delivery of a safe and effective endometrial ablation for the treatment of menorrhagia in a simple, office-based procedure that takes only minutes. With a vision to expand safe and effective treatment options to more patients, and provide physicians with the confidence and convenience necessary to perform office-based procedures, AEGEA is inspiring new approaches to women’s healthcare. Founded in 2008, AEGEA Medical is located in in Menlo Park, California.
LightPole is designed to give you information you're interested in about points of interest (POI)—locations such as your current location or locations you're traveling to. For any location, LightPole is designed to answer the most probable questions in the shortest amount of time and with the least amount of interaction.
ViVOtech, founded in 2001, specializes in providing software solutions for contactless and near field communications (NFC) payments. The company offers a range of products, including NFC payment systems, smart posters, and over-the-air card provisioning software, which facilitate mobile payments and promotional activities. Its ViVOnfc software supports mobile payment transactions, while the ViVOplatform enables retailers to manage promotional and loyalty applications effectively. ViVOtech's solutions cater to various sectors, including movie theaters, fast food restaurants, convenience stores, and public transportation, enhancing customer experience and operational efficiency. In October 2012, its Software Division was acquired by Sequent Software, expanding its reach in the secure mobile payments market.
Ravenflow enables enterprises to deliver applications faster. RAVEN software for requirements elicitation and definition quickly builds stakeholder consensus on requirements, reduces the time required for stakeholders to approve specifications, reduces developer rework due to requirements errors, and seamlessly integrates requirements and testing. RAVEN integrates requirements elicitation and definition with the application lifecycle management platforms from IBM Rational, Telelogic, HP Mercury, and also Microsoft Visual Studio.
Local delivery companies do everything in a supply chain’s “last mile,” from installing appliances to delivering critical parts within an hour of ordering. Local delivery is a $46 billion industry and typically accounts for 28% of a company's transportation spend, yet most companies overlook this critical step in the supply chain despite the fact that customer loyalty and sales are closely tied to the delivery experience.
Ensenda is the leading third party logistics provider (3PL) for the local delivery industry. Ensenda’ network of local carriers provides a wide range of local delivery programs in every market in the US and Canada
Arbor Surgical Technologies, Inc. located in Irvine and Portola Valley, CA (USA), is a privately held cardiovascular medical device company focused on the heart valve replacement market. Founded in 2002 by Dr. Thomas J. Fogarty and noted heart valve designer, Ernie Lane, Arbor is developing multiple technologies that have the potential to deliver significant clinical benefit to patients worldwide. Arbor intends to develop and commercialize its core technologies in varying combinations, giving the company the opportunity to create a portfolio of product offerings. Currently in clinical trials, Arbor is developing a tissue heart valve family of products designed for improved performance over existing valves and compatible implantation tools that simplify and speed valve replacement surgery.
Zest Labs specializes in on-demand data visibility solutions, focusing on cold chain and asset management. The company offers advanced XC3 Extended Capability RFID products and technologies that facilitate various applications, including temperature monitoring for perishable food and pharmaceuticals, asset tracking in construction and remote worksites, and vehicle and yard management. By providing real-time monitoring, Zest Labs helps organizations minimize shrinkage and loss, improve asset tracking and management, lower operational costs, and enhance profitability.
Qwaq was renamed to Teleplace and is now 3D Immersive Collaboration Consulting. See www.3dicc.com. Qwaq is a company building enterprise applications that use 3D virtual environments for realtime collaboration and conferencing. Qwaq's flagship product, Qwaq forums, includes built-in voice communication and text chat, as well as the ability for users to share existing applications. The underlying system is built on top of Croquet, an open source 3D space system manager. Users begin as they enter a virtual room, occupied by other users and objects like tables and posters on the walls. Many of those objects are standard desktop items -- a poster on the wall, for example, might be a Word document or Excel spreadsheet. When users click on the poster from "across" the room, or access it via keyboard shortcut, it expands to fill up their screen. In addition to chatting with the other users, users can add or subtract objects, or move through different rooms as desired. Qwaq Forums is designed for business computers, which tend to be less powerful than home computers. France based [Tixeo](http://www.tixeo.com/), is another start-up focused on the same market. A slew of other companies offering tools to set up and collaborate in virtual worlds include [Second Life](http://www.crunchbase.com/organization/secondlife), [VastPark](http://www.vastpark.com/), [ProtonMedia](http://www.protonmedia.com/), [Forterra Systems](http://www.forterrainc.com/), and [Multiverse](http://www.crunchbase.com/organization/Multiverse).
AnaptysBio, Inc. is a clinical-stage biotechnology company based in San Diego, California, focused on developing therapeutic antibodies for inflammation and immuno-oncology. The company’s key product candidates include Etokimab, an anti-IL-33 treatment for atopic dermatitis, eosinophilic asthma, and chronic rhinosinusitis; ANB019, an anti-IL-36 receptor for generalized pustular psoriasis; and several immune cell modulating antibodies, including checkpoint agonists for autoimmune diseases. AnaptysBio's pipeline features notable immuno-oncology candidates such as TSR-042 (anti-PD-1), TSR-022 (anti-TIM-3), and TSR-075 (anti-PD-1/LAG-3 bispecific). The company employs a proprietary platform based on somatic hypermutation for antibody discovery and optimization, addressing unmet medical needs in therapeutic applications. AnaptysBio has formed partnerships with various organizations, including TESARO and Celgene, to enhance its research and development efforts. Founded in 2005, AnaptysBio has established itself in the biotechnology sector as a developer of innovative therapies targeting significant health challenges.
Xangati, Inc. specializes in IT operations analytics and performance management for virtualized, private, and hybrid-cloud environments. Established in 2003 and headquartered in San Jose, California, Xangati offers a service assurance analytics framework that operates within the systems administrator's hypervisor, delivering highly granular performance metrics. The company's core products, including Xangati ESP for Cloud Workspace and Cloud Infrastructure, enable effective monitoring of application performance and capacity utilization while providing insights through cross-referenced application-level metrics and physical device interdependencies. Xangati's solutions facilitate the identification, analysis, and remediation of performance issues, helping organizations optimize their IT infrastructure and enhance end-user experience. The company serves a diverse clientele, including enterprises, government agencies, healthcare organizations, academic institutions, and cloud service providers, and has been utilized by notable clients such as Comcast and Harvard University. As of October 2016, Xangati operates as a subsidiary of Virtual Instruments Corporation.
Restoration Robotics is a privately held medical device company focused on advancing hair transplantation technology. The company has developed the ARTAS™ System, an innovative image-guided platform that facilitates follicular unit extraction. This system is notable for being the only computer-assisted, physician-controlled robotic solution for harvesting hair follicles, which enhances the precision and efficiency of the hair restoration process. By combining cutting-edge robotics with medical expertise, Restoration Robotics aims to improve outcomes for patients seeking hair restoration solutions.
KFx Medical specializes in the development and manufacturing of innovative soft tissue fixation implants aimed at orthopedic sports medicine. The company provides a system designed for tissue fixation, offering products that can be directly placed into bones, both with and without sutures. These implants are utilized in various orthopedic surgical procedures, allowing surgeons to effectively reattach tissue in areas such as the shoulder, knee, foot, and ankle. By collaborating with leading orthopedic surgeons, KFx Medical focuses on advancing technology and delivering reliable surgical implants, ultimately aiming to enhance surgical outcomes for patients.
ViVOtech, founded in 2001, specializes in providing software solutions for contactless and near field communications (NFC) payments. The company offers a range of products, including NFC payment systems, smart posters, and over-the-air card provisioning software, which facilitate mobile payments and promotional activities. Its ViVOnfc software supports mobile payment transactions, while the ViVOplatform enables retailers to manage promotional and loyalty applications effectively. ViVOtech's solutions cater to various sectors, including movie theaters, fast food restaurants, convenience stores, and public transportation, enhancing customer experience and operational efficiency. In October 2012, its Software Division was acquired by Sequent Software, expanding its reach in the secure mobile payments market.
Adzilla New Media, Inc. is a technology company headquartered in Brisbane, California, founded in 2002. It specializes in developing edge-of-network media delivery products, including ZILLAcasting, an innovative online content management and distribution system that focuses on precise audience targeting. Adzilla's platform allows internet service providers to deliver targeted advertising utilizing action-based behavioral and demographic data, enhancing the effectiveness of ad placements on publisher sites and advertising networks. The company's services cater to a diverse clientele, including advertisers, agencies, media companies, content providers, web publishers, and internet service providers. Adzilla is recognized for its commitment to improving online advertising through advanced targeting techniques.
Apptera is a mobile communications and advertising company that specializes in delivering multimedia content and interactive experiences to mobile devices. Its flagship product, Raved, enhances consumer engagement while the Apptera MobileAd Network connects advertisers with a diverse array of publishers, enabling effective outreach to millions of mobile users. The company collaborates with notable partners such as AOL Moviefone and Movietickets.com to maximize advertising impact. Founded in 2001 and based in Silicon Valley, Apptera has received several industry accolades, including recognition as one of the OnMobile 100 Top Private Companies in 2011. The company also holds multiple patents related to its communications technology, underscoring its innovative approach in the mobile advertising space. Apptera maintains additional offices in New York and Los Angeles, reflecting its expansive operational footprint.
3Leaf Systems specializes in server virtualization solutions that enhance corporate data center initiatives, focusing on power management and optimized scale-out architectures. Their Virtual Compute Environment (VCE) architecture provides system-level virtualization, allowing organizations to achieve mainframe-class capabilities on commodity servers. By utilizing 3Leaf's technology, businesses can significantly lower their infrastructure and operational costs while enabling rapid deployment and provisioning of data center resources. This ensures that organizations can meet the demands of modern applications effectively.
Hightail is a cloud service that lets users send, receive, digitally sign, and synchronize files. Hightail addresses the problems of creative collaboration and visual project management between teams of creative professionals and their clients and other stakeholders. An innovator in the cloud since before the term was even coined, Hightail (FKA YouSendIt) began as a simple way to send files that were too large for email and have since grown to evolve the cloud into a virtual workspace that enables seamless collaboration on visual projects from concept to completion.
Xactly is a prominent global provider of cloud-based Sales Performance Management solutions designed to enhance the effectiveness of sales organizations. The company offers tools for sales quota and territory planning, as well as incentive compensation management and predictive analytics. Its Xactly Incent Suite is specifically designed to drive sales behavior in alignment with organizational goals, promoting employee trust and loyalty through accurate commission payments and transparent access to performance data. By improving operational efficiency and productivity, Xactly aims to empower organizations to optimize their sales strategies and achieve better results.
Mavenir is a cloud-native network software provider that focuses on transforming network infrastructure for Communications Service Providers (CSPs). The company offers a comprehensive product portfolio that spans all layers of network infrastructure, including 5G applications, packet core, and radio access networks (RAN). Mavenir's innovative solutions have established it as a leader in evolved networking, with notable advancements in technologies such as VoLTE, VoWiFi, Advanced Messaging, and virtualized RAN. The company serves over 250 CSP customers in more than 130 countries, impacting more than half of the world's subscribers. By leveraging disruptive technologies and business models, Mavenir aims to enhance service agility, flexibility, and efficiency while helping CSPs reduce costs and protect revenue.
Cambridge Heart, Inc. specializes in the research, development, and commercialization of non-invasive diagnostic products for cardiac diseases. The company offers several key products, including the Heartwave II System, designed for conducting Microvolt T-Wave Alternans (MTWA) tests, and the CH2000 Cardiac Stress Test System, which supports a variety of standard and customized protocols for cardiac exercise testing. Additionally, it provides Micro-V Alternans Sensors, which are single-use, multi-segment electrodes utilized in MTWA tests. Cambridge Heart markets its products to cardiology group practices, hospitals, and research institutions, both in the United States and internationally through independent distributors. Founded in 1990, the company is based in Tewksbury, Massachusetts.
Cambrios Technologies Corp. develops electronic materials for the display industry. The company provides wet-processable transparent conductive films. Its nanostructured materials can be deposited using existing production equipment to achieve enhanced performance of display devices and components. The company was founded in 2002 as Semzyme, Inc. and changed its name to Cambrios Technologies Corp. in August 2004. Cambrios Technologies Corp. is based in Sunnyvale, California.
Teradici Corporation specializes in PC-over-IP (PCoIP) technology, which facilitates the transfer of images from centralized servers or workstations to various PCoIP-ready endpoints. This technology enhances the provisioning and management of computing services, supporting diverse work styles including remote, mobile, and collaborative environments. Teradici's offerings encompass a range of solutions such as zero clients, optimized thin clients, hardware accelerators, remote workstation cards, workstation access software, and a management console for enterprise deployment. These products cater to industries like education, financial services, healthcare, media and entertainment, and architecture, among others. The company also provides cloud solutions, desktop virtualization infrastructure, and support services. Teradici's clientele includes Fortune 500 companies, government agencies, and cloud service providers, and it collaborates with OEM partners globally. Founded in 2004 and headquartered in Burnaby, Canada, Teradici is committed to innovation and has secured over 40 patents in its field.
Pacific Biosciences designs, develops, and manufactures advanced sequencing systems that address complex genetic challenges. Utilizing single molecule real-time (SMRT) sequencing technology, it enables the real-time detection of biological processes at the single-molecule level. The company offers products such as the PacBio RS II and Sequel Systems, which are capable of conducting, monitoring, and analyzing biochemical reactions in real time. In addition to sequencing systems, Pacific Biosciences provides consumables like SMRT cells and various reagent kits essential for template preparation, binding, and sequencing. Its diverse customer base includes research institutions, commercial laboratories, genome centers, and various sectors such as pharmaceuticals and agriculture. The company markets its products through a direct sales force in North America and Europe, along with distribution partners in Asia, the Middle East, and Latin America. Founded in 2000, Pacific Biosciences is headquartered in Menlo Park, California.
Fluidigm Corporation develops and markets innovative technologies and tools for life sciences research globally. The company specializes in integrated fluidic circuits that control fluids at the nanoscale, enabling a range of applications in biological research. Its product offerings include analytical systems such as the Helios CyTOF system, the Hyperion imaging system, and the Biomark HD system, along with various assays and reagents designed for immuno-oncology and genetic analysis. Fluidigm also provides preparatory instruments and single-cell microfluidics, such as the C1 and Polaris systems. The company serves a diverse clientele, including academic institutions, clinical research laboratories, biopharmaceutical, biotechnology, and agricultural biotechnology companies, focusing on non-diagnostic and non-clinical applications. Established in 1999 as Mycometrix Corporation, it adopted the name Fluidigm Corporation in 2001 and is headquartered in South San Francisco, California.
Codon Devices
Series B in 2006
Codon Devices is a biotechnology company, engages in developing, constructing, and delivering synthetic biology products for research. The company focuses on discovering and manufacturing synthetic biological parts. Its BioLOGIC Engineering Platform combines sophisticated design algorithms with assay and protein engineering capabilities to result in a system for the design, discovery, and optimization of proteins for specific applications; and BioFAB Production Platform, which produces synthetic genes.
MontaVista Software is the leader in embedded Linux commercialization. They help you get the most of open source by providing commercial quality Linux and developer tools that significantly reduce the time and effort required to deliver commercial products to market. Combine that with their expert support, hardware enablement, and the resources of the MontaVista community and you can see why there are over 50 million devices in the market today running on MontaVista Linux.
Retrevo is an online shopping platform dedicated to consumer electronics, offering a comprehensive service for product search, discovery, recommendations, and purchasing. It aggregates and analyzes information from various sources, including expert reviews, user feedback, and technical manuals, to provide users with insightful and objective guidance on a wide range of electronic products such as cameras, laptops, audio equipment, and more. Utilizing machine learning and big data analytics, Retrevo continually updates its offerings to ensure consumers have access to the latest information and trends in the electronics market. Competing with other consumer electronics platforms, Retrevo positions itself as a leading resource for individuals looking to make informed purchasing decisions.
Hightail is a cloud service that lets users send, receive, digitally sign, and synchronize files. Hightail addresses the problems of creative collaboration and visual project management between teams of creative professionals and their clients and other stakeholders. An innovator in the cloud since before the term was even coined, Hightail (FKA YouSendIt) began as a simple way to send files that were too large for email and have since grown to evolve the cloud into a virtual workspace that enables seamless collaboration on visual projects from concept to completion.
Polimetrix
Series A in 2006
Polimetrix engages in survey research and analytics for research needs. The company provides BrandIndex, an information product that collects responses and calculates BIX net metrics based on the responses. It offers consulting, online survey, and online qualitative services. Polimetrix conducts surveys and polls for democratic, republican, and independent consultants; market research agencies; corporate public affairs groups; media organizations; university researchers; and non-profit organizations through its Website. The company was founded in 2004 and is headquartered in Palo Alto, California. Polimetrix, Inc. operates as a subsidiary of YouGov PLC.
Attune Systems, Inc. specializes in network file management solutions aimed at simplifying file management for enterprise, government, and educational sectors. The company offers the Maestro File Manager, a file virtualization appliance designed to assist IT administrators in discovering, analyzing, managing, and optimizing heterogeneous file storage resources. In addition to file management, Attune Systems provides services such as archive intelligence, security diligence, data migration and consolidation, disaster recovery, forensic search, and tiered backup and storage with deduplication. Founded in 1999 and headquartered in Santa Clara, California, the company has established strategic partnerships with prominent technology firms including Microsoft, Data Domain, NetApp, Symantec, and Google. However, it has recently experienced significant changes and has become less prominent in the industry.
Ciranova, Inc. operates as an electronic design automation company. It focuses on building interoperable tools for custom chip designers to create new and/or migrate legacy analog IP. It offers products, such as PyCell Studio, which helps designers reduce the time and cost of PCell and layout generator creation for deep submicron processes; and PCell Xtreme, which enables the migration of PCells created in proprietary languages into multi-vendor OpenAccess flows. It provides custom layout generator development, Python code development consulting, custom layout consulting, and analog and mixed signal design services. The company was founded in 2002 and is headquartered in Santa Clara, California.